Shopping Cart 0
Cart Subtotal
USD 0

Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Myriad Genetics Inc (MYGN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company's product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient's likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

Myriad Genetics Inc Key Recent Developments

Aug 21,2018: Myriad Genetics reports fiscal fourth-quarter and full-year 2018 financial results

May 28,2018: Myriad Genetics Signs Definitive Agreement to Acquire Counsyl

May 08,2018: Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results

May 04,2018: Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer

Apr 23,2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Myriad Genetics Inc-Key Facts 6

Myriad Genetics Inc-Key Employees 7

Myriad Genetics Inc-Key Employee Biographies 8

Myriad Genetics Inc-Major Products and Services 9

Myriad Genetics Inc-History 11

Myriad Genetics Inc-Company Statement 18

Myriad Genetics Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Section 2-Company Analysis 21

Company Overview 21

Myriad Genetics Inc-Business Description 22

Business Segment: Diagnostics Segment 22

Overview 22

Performance 22

Business Segment: Other Segment 22

Overview 22

Performance 22

R&D Overview 22

Myriad Genetics Inc-Corporate Strategy 23

Myriad Genetics Inc-SWOT Analysis 24

SWOT Analysis-Overview 24

Myriad Genetics Inc-Strengths 24

Myriad Genetics Inc-Weaknesses 25

Myriad Genetics Inc-Opportunities 26

Myriad Genetics Inc-Threats 27

Myriad Genetics Inc-Key Competitors 28

Section 3-Company Financial Ratios 29

Financial Ratios-Capital Market Ratios 29

Financial Ratios-Annual Ratios 30

Performance Chart 33

Financial Performance 33

Financial Ratios-Interim Ratios 34

Financial Ratios-Ratio Charts 35

Section 4-Company's Lifesciences Financial Deals and Alliances 36

Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 36

Myriad Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 37

Myriad Genetics Inc, Recent Deals Summary 38

Section 5-Company's Recent Developments 39

Aug 21, 2018: Myriad Genetics reports fiscal fourth-quarter and full-year 2018 financial results 39

May 08, 2018: Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results 42

May 07, 2018: Genome Medical Enters Employer Market with Diverse Genetic Health Programs and Wave of New Partners 44

Apr 23, 2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc. 45

Apr 18, 2018: Counsyl to offer insight into streamlining genetic screening into OBGYN practice at the 2018 ACOG Annual Clinical and Scientific Meeting 46

Apr 04, 2018: Counsyl Highlights Importance of Patient Access to Genetic Testing at the 2018 ACMG Annual Clinical Genetics Meeting 47

Feb 06, 2018: Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results 49

Jan 04, 2018: Counsyl Appoints Ann Rhoads to Board of Directors 51

Dec 14, 2017: Counsyl Appoints Pamela Sedmak to Board of Directors 52

Dec 04, 2017: Counsyl Appoints Noah Nasser as Chief Commercial Officer 53

Section 6-Appendix 54

Methodology 54

Ratio Definitions 54

About GlobalData 58

Contact Us 58

Disclaimer 58


List Of Figure

List of Figures

Myriad Genetics Inc, Performance Chart (2014-2018) 33

Myriad Genetics Inc, Ratio Charts 35

Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 36

Myriad Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 37


List Of Table

List of Tables

Myriad Genetics Inc, Key Facts 6

Myriad Genetics Inc, Key Employees 7

Myriad Genetics Inc, Key Employee Biographies 8

Myriad Genetics Inc, Major Products and Services 9

Myriad Genetics Inc, History 11

Myriad Genetics Inc, Subsidiaries 19

Myriad Genetics Inc, Key Competitors 28

Myriad Genetics Inc, Ratios based on current share price 29

Myriad Genetics Inc, Annual Ratios 30

Myriad Genetics Inc, Annual Ratios (Cont...1) 31

Myriad Genetics Inc, Annual Ratios (Cont...2) 32

Myriad Genetics Inc, Interim Ratios 34

Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 36

Myriad Genetics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 37

Myriad Genetics Inc, Recent Deals Summary 38

Currency Codes 54

Capital Market Ratios 54

Equity Ratios 55

Profitability Ratios 55

Cost Ratios 56

Liquidity Ratios 56

Leverage Ratios 57

Efficiency Ratios 57

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Myriad Genetics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Siemens Healthcare GmbH

Nanosphere Inc

Hologic Inc

Exact Sciences Corp

Amgen Inc

Affymetrix, Inc.

Abbott Laboratories